info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > GPR
GPR
Cat.No. Product Name Information Area
T3433 TUG-891 TUG 891 is a potent and selective GPR120 agonist as a new potential target for treatm... Other
T3119 JNJ-63533054 JNJ-63533054 is a potent and selective agonist of hGPR139 with an EC50 = 16 nM. Others
T3176 APD597 APD597 is a GPR119 agonist intended for the treatment of type 2 diabetes, with EC50 o... Metabolism system
T3171 GSK137647A GSK137647A is a selective FFA4 agonist, with pEC50 of 6.3, 6.2, and 6.1 for human, Mo... Metabolism system
T6399 AZD1981 AZD1981 is a potent, selective CRTh2 (DP2) receptor antagonist with IC50 of 4 nM, sho... Endocrine system
T2351L TAK-875 Hemihydrate TAK-875 is a selective GPR40 agonist with EC50 of 14 nM, 400-fold more potent than ol... Endocrine system
T2701 GSK1292263 GSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 d... Endocrine system
T2664 OC000459 OC000459 is a potent and selective D prostanoid receptor 2 (DP2) antagonist with IC50... Endocrine system
T2351 TAK-875 TAK-875 is a selective GPR40 agonist with EC50 of 14 nM in human GPR40 expressing CHO... Endocrine system
T2088 APD668 APD668 is a potent GPR119 agonist with EC50 of 2.7 nM and 33 nM for hGPR119 and ratGP... Other
T2058 ACT 058362; Palosuran Palosuran (ACT-058362) is a new potent and specific antagonist of the human UT recept... Other
T2036 6-OAU 6-OAU(GTPL5846; 6-n-octylaminouracil) is a surrogate agonist of GPR84; activates huma... Other
T1793 MBX-2982 MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 ... Endocrine system
T1781 GW9508 GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32, 100-fol... Endocrine system
1